The eye relies on a series of thin, specialized membranes to stay clear, hydrated, and functional. These membranes are not just passive barriers. They actively pump fluid, anchor cells, filter nutrients, block pathogens, and maintain the transparency that makes vision possible. When any one of them breaks down or grows where it shouldn’t, the consequences range from mild irritation to permanent vision loss. Understanding what these membranes do, what can go wrong with them, and how modern medicine repairs or replaces them covers a surprisingly wide territory in eye health.
Membranes of the Cornea
The cornea alone contains several membrane layers stacked like the pages of a book, each with a distinct job. Starting from the front of the eye and moving inward, the first significant membrane is the epithelial basement membrane (EBM). This ultrathin sheet anchors the outermost corneal cells in place. Directly beneath it sits Bowman’s layer, a dense, acellular sheet found in humans and some other species. Researchers believe Bowman’s layer forms through signaling interactions between the surface epithelial cells and the structural cells (keratocytes) deeper in the cornea during development.1PubMed Central. Bowman’s layer in the cornea- structure and function and regeneration It provides mechanical support and helps maintain the smooth optical surface the cornea needs for sharp focus.
At the back of the cornea, Descemet’s membrane serves as the basement membrane for the corneal endothelium, the single-cell layer that keeps the cornea from swelling up with fluid. Descemet’s membrane supports those endothelial cells and helps maintain corneal transparency and fluid balance.2PubMed. Artificial substitutes for Descemet’s membrane – corneal endothelium complex: state of the art The endothelial cells themselves work through a pump-and-leak mechanism: they actively transport ions out of the cornea, drawing water with them and counteracting the natural tendency of the corneal stroma to swell.3PubMed Central. Molecular mechanisms underlying the corneal endothelial pump If this pump fails or the endothelial cell count drops too low, the cornea becomes waterlogged and cloudy.
The Mucin Layer and Tear Film
Sitting on top of the cornea and the conjunctiva (the clear tissue that lines the inner eyelids and covers the white of the eye), a mucin layer forms the innermost component of the tear film. Both the cornea and the conjunctiva produce membrane-spanning mucins, while the conjunctiva also secretes soluble mucins through specialized goblet cells. Together, these mucins keep the eye’s surface hydrated, provide lubrication during blinking, prevent adhesion between tissue surfaces, and create a barrier that stops pathogens from binding to the eye.4PubMed Central. Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins
When mucin production goes wrong, the consequences are felt quickly. Changes in mucin expression on corneal and conjunctival cells, or reduced mucin secretion by goblet cells, destabilize the tear film. That instability accelerates tear evaporation, which can push tear chemistry toward higher salt concentrations that trigger inflammation on the eye’s surface. This chain of events is now recognized as a central driver in dry eye disease.5PubMed. Reconsidering the central role of mucins in dry eye and ocular surface diseases Treatments for dry eye often focus on restoring the tear film’s lipid or aqueous layers, but mucin loss is a frequently overlooked piece of the puzzle.
Bruch’s Membrane and the Retinal Layers
Deeper in the eye, Bruch’s membrane is a five-layered sheet that separates the retinal pigment epithelium from the blood-vessel-rich choroid underneath. It acts as a selective filter, allowing nutrients and oxygen to pass from the blood supply to the light-sensing retina while controlling waste removal in the opposite direction. As people age, metabolic changes in the pigment epithelium alter Bruch’s membrane, leading to lipid buildup and the formation of deposits called drusen.6PubMed. Drusen in Bruch’s membrane. Their significance for the pathogenesis and therapy of age-associated macular degeneration These drusen are the hallmark early sign of age-related macular degeneration (AMD), one of the leading causes of vision loss in older adults.
On the retina’s inner surface, the internal limiting membrane (ILM) serves as the boundary between the retina and the vitreous gel that fills the eye’s interior. The ILM is normally thin and transparent, but problems arise when cells proliferate on its surface and form what is called an epiretinal membrane (ERM). An epiretinal membrane is essentially scar-like tissue that contracts and wrinkles the retina beneath it, distorting central vision. Similarly, when abnormal blood vessels grow through Bruch’s membrane into the retinal layers, the result is a choroidal neovascular membrane (CNVM), a condition that can cause rapid, severe vision loss if untreated.
Conjunctival Conditions and Pterygium
The conjunctiva itself can develop abnormal membrane-like growths. A pterygium is a wedge-shaped growth of fibrovascular tissue that typically starts on the white of the eye near the nose and can slowly creep onto the cornea, eventually threatening vision. Its development is strongly linked to ultraviolet light exposure, though researchers have also identified roles for oxidative stress, inflammatory mediators, DNA changes, and disruptions in programmed cell death.7Seminars in Ophthalmology. Molecular Basis of Pterygium Development People who spend years working outdoors in sunny climates are at the highest risk.
A more serious conjunctival problem is symblepharon, where bands of scar tissue fuse the conjunctiva of the eyelid to the conjunctiva covering the eyeball. This typically follows severe inflammatory events such as Stevens-Johnson syndrome, chemical burns, or other forms of ocular surface damage. Ongoing inflammation causes chronic scarring, abnormal eyelash growth, and changes to the eyelid margins, all of which disrupt the normal tear film, impair blinking, and can limit eye movement.8PubMed Central. Symblepharon as Ocular Manifestation Post Stevens-Johnson Syndrome: A Rare Case These cases often require complex, staged surgical reconstruction.
Conditions of the Corneal Membranes
Fuchs endothelial corneal dystrophy (FECD) is one of the most common reasons corneal membranes fail. In Fuchs, the endothelial cells that line the back of the cornea die off progressively, and Descemet’s membrane thickens with abnormal deposits of extracellular material called guttae. These tiny excrescences, visible under high magnification, disrupt the endothelial pump function. Over time the cornea swells, clouds over, and vision deteriorates.9PubMed Central. Fuchs endothelial corneal dystrophy Fuchs tends to run in families and progresses slowly, often not causing noticeable symptoms until middle age or later.
At the front of the cornea, epithelial basement membrane dystrophy (EBMD), sometimes called map-dot-fingerprint dystrophy, involves abnormal production of the basement membrane that anchors the surface epithelium. The resulting irregular membrane and tiny cysts within the epithelium create weak spots where the surface cells can detach, causing painful recurrent corneal erosions. Even minor mechanical contact with the eye can trigger a flare-up, as demonstrated in a case where routine clinical testing exacerbated previously subclinical disease.10PubMed Central. Pachymetry-induced exacerbation of map-dot-fingerprint dystrophy
When corneal basement membranes are injured and fail to regenerate properly, a different problem emerges: stromal fibrosis, commonly known as corneal scarring. The current understanding is that defective regeneration of either the EBM or Descemet’s membrane allows certain growth factors to penetrate the corneal stroma at levels high enough to drive the formation of opacity-producing cells called myofibroblasts. Key structural components of healthy basement membranes normally bind and regulate these growth factors, keeping them in check.11PubMed Central. The Corneal Basement Membranes and Stromal Fibrosis Once the basement membrane rebuilds itself properly, fibrosis can resolve and transparency gradually returns, though severe cases may leave permanent haze.
Surgical Treatments for Membrane Disorders
The most significant surgical advance for Fuchs dystrophy in recent years is Descemet membrane endothelial keratoplasty (DMEK). Rather than replacing the entire cornea, DMEK selectively transplants a thin graft of donor Descemet’s membrane and its attached endothelial cells through a small incision. This approach targets only the diseased layer and can provide rapid visual recovery for people with corneal endothelial dysfunction.12PubMed. Descemet membrane endothelial keratoplasty (DMEK) The American Academy of Ophthalmology has reviewed published studies on DMEK’s safety and outcomes, confirming it as a viable treatment for endothelial disease.13PubMed. Descemet Membrane Endothelial Keratoplasty: Safety and Outcomes: A Report by the American Academy of Ophthalmology
For epiretinal membranes that distort vision enough to warrant intervention, vitrectomy with membrane peeling is the standard approach. The surgeon removes the vitreous gel and carefully peels the abnormal membrane off the retinal surface. A key decision during surgery is whether to also peel the internal limiting membrane underneath. Meta-analyses have found that adding ILM peeling results in better long-term visual improvement and substantially lower recurrence rates, with recurrence dropping from roughly one in six patients to fewer than one in thirty.14Ophthalmologica. Pars Plana Vitrectomy with or without Internal Limiting Membrane Peel for Epiretinal Membrane: A Systematic Review and Meta-Analysis However, peeling only the epiretinal membrane (without touching the ILM) appears better at reducing retinal thickness, so the trade-off is worth discussing with a surgeon.15PLoS ONE. Vitrectomy with or without internal limiting membrane peeling for idiopathic epiretinal membrane: A meta-analysis
Amniotic membrane transplantation has become a workhorse in ocular surface reconstruction. Donor amniotic membrane, harvested from human placentas, promotes healing and suppresses inflammation when placed over damaged corneal or conjunctival tissue. In patients with deep corneal ulcers, multilayer amniotic membrane grafts consistently reduced inflammation within days and improved comfort without apparent side effects like infection.16Ophthalmology. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers Amniotic membrane is also used after pterygium removal, though it may carry a higher recurrence rate compared to conjunctival autograft. In one comparative study, recurrence was about 14% with amniotic membrane versus about 5% with conjunctival autograft, although the difference did not reach statistical significance.17PubMed. Recurrence After Primary Pterygium Excision: Amniotic Membrane Transplantation with Fibrin Glue Versus Conjunctival Autograft with Fibrin Glue
Non-Surgical Approaches
For choroidal neovascular membranes that threaten central vision, injections of anti-VEGF drugs have become the go-to treatment. These medications block the growth signal that drives abnormal blood vessel formation. In inflammatory CNVM cases, anti-VEGF injections combined with control of the underlying inflammation have produced significant visual improvement and complete resolution of the abnormal membrane, often requiring only a few injections per eye.18RETINA. INFLAMMATORY CHOROIDAL NEOVASCULAR MEMBRANE These agents are now considered the most commonly used treatment for CNVM related to uveitis, with relatively low recurrence rates.19PubMed Central. Inflammatory Choroidal Neovascular Membranes in Patients With Noninfectious Uveitis: The Place of Intravitreal Anti-VEGF Therapy
When the corneal surface fails to heal on its own, autologous serum eye drops offer a biological alternative to conventional artificial tears. Made from a patient’s own blood serum, these drops contain growth factors, vitamins, and other components that mimic natural tears and actively support epithelial healing. In one study of persistent corneal epithelial defects that had resisted standard treatments, serum drops healed the defects in over 90% of eyes, with most healing within four weeks.20PubMed. Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects A separate study found that about 63% of persistent defects healed within a month of starting serum therapy.21PubMed. Treatment of persistent corneal epithelial defect by autologous serum application These drops function not just as lubricants but as genuine tissue-repair agents, supplying the same healing signals that the tear film normally delivers.22Scientific Reports. Undiluted Serum Eye Drops for the Treatment of Persistent Corneal Epitheilal Defects
Engineered Membranes and Future Directions
Researchers are now building artificial versions of the eye’s own membranes. One approach creates engineered basement membranes using thin layers of the same proteins found in native Descemet’s membrane, attached to a collagen scaffold. In laboratory testing, human corneal endothelial cells grown on these engineered membranes formed the tight, dense monolayers needed for a functional pump, suggesting they could eventually serve as transplant-quality grafts.23PubMed Central. Engineered Basement Membranes for Regenerating the Corneal Endothelium This would be a significant step toward reducing dependence on donor corneas, which remain in short supply worldwide.
Other groups have developed synthetic versions of Bowman’s membrane paired with a stromal layer, creating a dual-layered construct that mimics the front half of the cornea. In testing, the synthetic Bowman’s layer promoted rapid surface cell growth and maturation, while the stromal layer supported the deeper structural regeneration needed for a full corneal substitute.24PubMed Central. Multifunctional synthetic Bowman’s membrane-stromal biomimetic for corneal reconstruction Broader work on tissue-engineered corneal scaffolds combining natural and synthetic materials continues to push the field toward a fully artificial cornea.25PubMed Central. Evaluation of corneal cell growth on tissue engineering materials as artificial cornea scaffolds
Drug delivery is another area where membranes play a growing role. Conventional eye drops are notoriously inefficient; roughly 95% of the medication is lost through tear drainage before it can do any good. Soft contact lenses designed to release drugs slowly are being developed as an alternative. The lens traps medication between two thin tear layers on either side of the contact, extending the time it stays in contact with the eye’s surface and dramatically reducing waste.26PubMed Central. Soft Contact Lenses as Drug Delivery Systems: A Review If these reach widespread clinical use, they could change how conditions like dry eye, glaucoma, and post-surgical inflammation are managed, turning a familiar device into a membrane-based pharmacy sitting right on the eye.